Why Amazon’s Healthcare Trio Is Undeniably BRILLIANT On January 30, 2018, Amazon, JP Morgan, and Berkshire Hathaway announced that they would form an independent health care company for their employees in the United States. Value versus Profit: The Dagger A direct...
DEA Reportedly Set to Revise SORS Guidelines and (Hopefully) Clarify the Meaning of “Suspicious” As the opioid crisis continues to grow and further entrench itself throughout the country, governments at the local, state, and federal level are desperately searching for...
HealthWarehouse.com – The Perfect Amazon Acquisition Companies across the United States have been on edge over the last couple of years as Amazon continues to win the hearts and wallets of consumers. Amazon recently obtained wholesale drug licensing which has fueled...
Biggest Industry Players Face Pressure from Public and the DEA on Suspicious Order Monitoring The Opioid Epidemic has been a devastating trend in America, starting in the late 1990s and continuing over twenty years through today. Experts believe that the glut of...
NABP Violating DSCSA, Lawsuit Pending Companies are starting to line up for a class action suit against the NABP, potentially reaching over 50 organizations across the United States. Background on the VAWD Standard It is VAWD standard that companies are “regularly...
